(Reuters) -The U.S. Food and Drug Administration has approved Regeneron's cancer therapy, the company said on Wednesday, ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...

Sean "Diddy" Combs' loved ones left Manhattan federal court to loud applause after the hip-hop mogul was convicted on two ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

Analysis shows Gilead’s recently approved drug for HIV prevention, Yeztugo, has the potential to transform the PrEP sector in the US.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

Researchers at Brown University’s School of Public Health found that children exposed to higher levels of triclosan may be ...